|Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series|
XW Xu, XX Wu, XG Jiang, KJ Xu, LJ Ying, CL Ma, SB Li, HY Wang, ...
bmj 368, 2020
|Alterations of the human gut microbiome in liver cirrhosis|
N Qin, F Yang, A Li, E Prifti, Y Chen, L Shao, J Guo, E Le Chatelier, J Yao, ...
Nature 513 (7516), 59-64, 2014
|Altered fecal microbiota composition in patients with major depressive disorder|
H Jiang, Z Ling, Y Zhang, H Mao, Z Ma, Y Yin, W Wang, W Tang, Z Tan, ...
Brain, behavior, and immunity 48, 186-194, 2015
|Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms|
X Jin, JS Lian, JH Hu, J Gao, L Zheng, YM Zhang, SR Hao, HY Jia, H Cai, ...
Gut 69 (6), 1002-1009, 2020
|A deep learning system to screen novel coronavirus disease 2019 pneumonia|
X Xu, X Jiang, C Ma, P Du, X Li, S Lv, L Yu, Q Ni, Y Chen, J Su, G Lang, ...
Engineering 6 (10), 1122-1129, 2020
|Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome|
Y Chen, W Liang, S Yang, N Wu, H Gao, J Sheng, H Yao, J Wo, Q Fang, ...
The Lancet 381 (9881), 1916-1925, 2013
|A predictive nomogram for predicting improved clinical outcome probability in patients with COVID-19 in Zhejiang Province, China|
J Xie, D Shi, M Bao, X Hu, W Wu, J Sheng, K Xu, Q Wang, J Wu, K Wang, ...
Engineering 8, 122-129, 2022
|Characterization of fecal microbial communities in patients with liver cirrhosis|
Y Chen, F Yang, H Lu, B Wang, Y Chen, D Lei, Y Wang, B Zhu, L Li
Hepatology 54 (2), 562-572, 2011
|Clinical findings in 111 cases of influenza A (H7N9) virus infection|
HN Gao, HZ Lu, B Cao, B Du, H Shang, JH Gan, SH Lu, YD Yang, Q Fang, ...
New England Journal of Medicine 368 (24), 2277-2285, 2013
|Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study|
J Wu, J Liu, X Zhao, C Liu, W Wang, D Wang, W Xu, C Zhang, J Yu, ...
Clinical infectious diseases 71 (15), 706-712, 2020
|The human microbiota in health and disease|
B Wang, M Yao, L Lv, Z Ling, L Li
Engineering 3 (1), 71-82, 2017
|Molecular architecture of the SARS-CoV-2 virus|
H Yao, Y Song, Y Chen, N Wu, J Xu, C Sun, J Zhang, T Weng, Z Zhang, ...
Cell 183 (3), 730-738. e13, 2020
|Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota|
Y Hu, X Yang, J Qin, N Lu, G Cheng, N Wu, Y Pan, J Li, L Zhu, X Wang, ...
Nature communications 4 (1), 2151, 2013
|Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent|
L Liu, K Xu, H Wang, PK Jeremy Tan, W Fan, SS Venkatraman, L Li, ...
Nature nanotechnology 4 (7), 457-463, 2009
|Management of COVID-19: the Zhejiang experience|
K Xu, H Cai, Y Shen, Q Ni, Y Chen, S Hu, J Li, H Wang, L Yu, H Huang, ...
Zhejiang da xue xue bao. Yi xue ban= Journal of Zhejiang University. Medical …, 2020
|Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza|
S Gu, Y Chen, Z Wu, Y Chen, H Gao, L Lv, F Guo, X Zhang, R Luo, ...
Clinical Infectious Diseases 71 (10), 2669-2678, 2020
|Biodegradable nanostructures with selective lysis of microbial membranes|
F Nederberg, Y Zhang, JPK Tan, K Xu, H Wang, C Yang, S Gao, XD Guo, ...
Nature chemistry 3 (5), 409-414, 2011
|Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19)|
K Xu, Y Chen, J Yuan, P Yi, C Ding, W Wu, Y Li, Q Ni, R Zou, X Li, M Xu, ...
Clinical infectious diseases 71 (15), 799-806, 2020
|Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China|
ZQ Wei, XX Du, YS Yu, P Shen, YG Chen, LJ Li
Antimicrobial agents and chemotherapy 51 (2), 763-765, 2007
|Dysbiosis signature of fecal microbiota in colorectal cancer patients|
N Wu, X Yang, R Zhang, J Li, X Xiao, Y Hu, Y Chen, F Yang, N Lu, ...
Microbial ecology 66, 462-470, 2013